NIH Spotlights Women's Health and BRAIN Tech Partnerships — No New Funding Announced

On April 7 the National Institutes of Health staged two high‑visibility events that showcased the agency’s current priorities — a milestone advisory‑committee meeting on women’s health at its Bethesda campus and an online applicant briefing tied to its BRAIN Initiative. While both sessions underscored themes that NIH leaders said matter — maternal health, inclusion, environmental exposures and spreading neuroscience tools beyond well‑funded labs — neither produced clear new funding announcements or formal policy changes.

Two events, one message

From 9 a.m. to 4 p.m. Eastern, the Office of Research on Women’s Health (ORWH) convened the 64th meeting of the Advisory Committee on Research on Women’s Health (ACRWH) in Building 31 on the NIH campus. The meeting doubled as a 35th‑anniversary commemoration for the office, which was created in 1990 to coordinate women’s health research and to integrate sex and gender considerations across NIH.

ACRWH is a statutory federal advisory committee established under the 1993 NIH Revitalization Act. It reviews the women’s health research portfolio, evaluates the inclusion of women and underrepresented groups in NIH‑funded clinical studies, and recommends priorities to ORWH leadership.

The agenda, led by executive secretary Lucia Hindorff and ORWH director Janine A. Clayton, M.D., highlighted several ongoing priorities: the IMPROVE initiative addressing pregnancy‑related morbidity and mortality; adherence to NIH inclusion policies; environmental exposures such as PFAS and microplastics; and the use of artificial intelligence and data science in women’s health research. Chloe E. Bird, Ph.D., delivered the scheduled keynote on health equity and women’s health, and the meeting included panels on environmental exposures and AI applications.

NIH livestreamed the meeting. As of April 7 there were no public transcripts or posted slide decks and no record of new funding notices tied to the session. The ACRWH agenda lists the next in‑person meeting for Oct. 20, 2026.

BRAIN webinar: clarifying an existing RFA

In the early afternoon, NIH’s BRAIN Initiative held an informational webinar titled “Promoting Health for All Through BRAIN Technology Partnerships Informational Webinar.” The session was an applicant Q&A for an already published funding opportunity (RFA‑NS‑25‑016) that uses the R34 mechanism and explicitly disallows clinical trials.

Key features of the RFA:

• Budgets are small: up to $225,000 in direct costs per year and a maximum of $450,000 for the project.
• The program is structured as a partnership between a "BRAIN disseminator" (an investigator or institution that has developed and shared a validated BRAIN technology) and a lead investigator at a resource‑limited institution.
• Resource‑limited institutions are defined as those that received no more than $7.5 million per year in NIH research project grant funding (total costs) in at least four of the past seven years.
• The RFA emphasizes dissemination and adoption of existing technologies; proposals to develop new tools or to conduct clinical trials are nonresponsive.

Program slides included an instruction in all caps: READ THE FUNDING OPPORTUNITY!, reinforcing that applicants must follow the published terms. The grants calendar notes the webinar was recorded and that resources would be posted within 7–10 business days.

As with the ORWH meeting, there was no public indication on April 7 that NIH used the webinar to change budget limits, add application dates, or otherwise revise the RFA. Any such modifications would normally appear in a revised funding announcement or a separate NIH Guide notice.

What this means for researchers and institutions

Both events served to reaffirm NIH priorities rather than to launch new programs. For investigators tracking women’s health, the ORWH agenda confirms continued emphasis on maternal health (IMPROVE), inclusion of women and underrepresented groups in research, environmental exposure science, and the application of AI and data science.

For neuroscience researchers and resource‑limited campuses, the BRAIN RFA remains an option for partnerships that expand access to validated technologies. The next listed application due dates are June 17, 2025, and June 17, 2026. Given the modest R34 budgets and the RFA’s focus on dissemination rather than tool development, broad expansion of access will likely require multiple awards and potentially follow‑on funding.

Waiting for the paper trail

Federal advisory meetings and applicant briefings are routine tools for NIH to communicate priorities and clarify program rules. However, until NIH posts ACRWH meeting minutes, videocast transcripts and slide decks, or publishes the BRAIN webinar recording and resources, there is limited documentary evidence that April 7 produced policy or budget changes beyond what is already written in current funding notices.

NIH stakeholders should monitor the Grants & Funding portal and the NIH Guide for Grants and Contracts for any revised notices or new funding opportunities that would formally alter the agency’s funding landscape.